CCR5 program (Millennium)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameCCR5 program (Millennium)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 5 antagonists
TargetsC-C chemokine receptor type 5
Therapy Area/IndicationsArthritis, RheumatoidHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMillennium Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMillennium Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsArthritis, RheumatoidHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A